Pay in 4 interest-free payments of $21.25 Learn more
Ships within 48 hours · Estimated delivery Aug 8 - Aug 13
EB-3D a novel choline kinase inhibitor induces deregulation of the AMPK-mTOR pathway and apoptosis in leukemia T-cells
InChi: InChI=1S/C19H14F3N3O3/c1-24-17(28)25(14-8-7-12(10-23)15(9-14)19(20
TG101348 (SAR302503)
Pretreatment with tangeretin inhibites IL-1beta-induced p38 MAPK
Formula: C16H15N3
GS-9973 - CAS# 1229208-44-9 aplatin EB-3D a novel choline kinaseEntospletinib, also known as GS 9973, is a highly selective and orally efficacious Syk inhibitor which is currently undergoing clinical evaluation for autoimmune and oncology indications. In Phase II clinical trials, Entospletinib demonstrates clinical activity in subjects with relapsed or refractory CLL with acceptable toxicity. Product information CAS Number: 1229208 44 9 Molecular Weight: 411. 46 Formula: C23H21N7O Synonym: Entospletinib GS9973 GS
US$ 35.00
US$ 12.00
US$ 30.00
US$ 16.00
US$ 15.00
US$ 42.00